Adial Pharmaceuticals Inc.

ADIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.40

-$0.46 (-9.47%)

At close: Sep 21, 2026, 4:00 PM ET

$4.48

+$0.08 (+1.82%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-9.47%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.22M

1D Range

4.23 4.82

52W Range

1.31 10.75

Valuation (TTM)

PE -0.27

PB 27.07

EV/EBITDA 0.42

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $8.50

Cash Flow

FCF Yield -263.7%

SBC Adj. FCF Yield -277.9%

SBC Impact -5.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 98.4% | 65.3%

FCF 3Y | 5Y -39.3% | 3.0%

Returns

ROA -198.7%

ROE -1693.2%

ROIC -240.6%

Financial Health

Net Cash

$28.71M

Current Ratio 5.63

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention ...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Jul 26, 2018

Website www.adial.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$8.50

Upside

+93.18%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞